Compare studies and check their requirements with the research team.
This study was withdrawn in the United States. It is testing SPD465 for ADHD.
In United States
This study is completed in the United States. It is testing SPG Block for Addiction.
In United States
This study is completed in the United States. It is testing spoken Language for Bipolarity.
In United StatesThis study is completed in the United States. It focuses on schizophrenia.
In United StatesThis study is completed in the United States. It is testing subjects Switched to Lurasidone for schizophrenia.
In United StatesThis study is completed in the United States, in the United Kingdom, in Belgium, .... It is testing TAK-503 for ADHD.
In United StatesThis study is completed in the United States. It is testing TD-9855 for ADHD.
In United StatesThis study is completed in the United States. It is testing cataractogenic Potential of Seroquel and Risperdal for schizophrenia.
In United StatesThis study is completed in the United States. It is testing Effect of RO4917838 on Biomarker Measures of Cognitive Dysfunction for schizophrenia.
In United StatesThis study is completed in the United States. It is testing effects of Sarcosine on Symptoms and Brain Glycine Levels for schizophrenia.
In United StatesThis study is completed in the United States, in Costa Rica, in Mexico, .... It is testing efficacy (Effectiveness) of Paliperidone Palmitate for schizophrenia.
In United StatesThis study is completed in the United States. It is testing SP-624 for depression.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.